Adnovate Clinical Development Strategies Ltd
Biotechnology company · Sidcup, England, United Kingdom
Adnovate Clinical Development Strategies Ltd is a biotechnology company headquartered in Sidcup, England, United Kingdom. Its earliest recorded incorporation is in 2014. It is registered with UK Companies House under company number 09272823.
Profile compiled from public records. Is this your company? Request a correction or update
Adnovate Clinical Development Strategies at a glance
Typebiotechnology company
HeadquartersSidcup, England, United Kingdom
Earliest incorporation on record2014
Registered activities (UK)Research and experimental development on biotechnology; Other professional, scientific and technical activities n.e.c.; Other business support service activities n.e.c.
UK company number09272823
Frequently asked questions about Adnovate Clinical Development Strategies
Where is Adnovate Clinical Development Strategies headquartered?
Adnovate Clinical Development Strategies Ltd is headquartered in Sidcup, England, United Kingdom.
What does Adnovate Clinical Development Strategies do?
Adnovate Clinical Development Strategies Ltd is a biotechnology company.
When was Adnovate Clinical Development Strategies founded?
The earliest incorporation on record for Adnovate Clinical Development Strategies Ltd is in 2014, according to public company registers.
Similar companies
- Bello Clinical Research LtdSidcup, England, United Kingdom
- Immunocore Holdings plcAbingdon, England, United Kingdom
- Adaptimmune Therapeutics PLCAbingdon, England, United Kingdom
- Orchard Therapeutics plcLondon, England, United Kingdom
- Gyroscope Therapeutics LtdLondon, England, United Kingdom
- Abcam plcCambridge, England, United Kingdom
- Inivata LtdCambridge, England, United Kingdom
- TC BioPharm (Holdings) plcHolytown, Scotland, United Kingdom
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences